Information:
Error:
ID
17540
Description
Study part: Comorbidities at study end LeMLAR-Studie. Lenalidomide in conjunction with methotrexate, leucovorin, cytarabine and rituximab for the treatment of relapsed or refractory CD20-positive aggressive lymphomas: an open-label, multicenter phase I/II trial. Publication granted by Prof. Dührsen and provided by Claudia Ose, University clinic Essen, NCT01788189, Version 1.3-28.04.2013.doc.
Keywords
Versions (1)
- 9/22/16 9/22/16 -
Uploaded on
September 22, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Comorbidities at study end LeMLAR-Studie Lymphoma NCT01788189
Comorbidities at study end
- StudyEvent: ODM
Similar models
Comorbidities at study end
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Comorbidity
Item
Begleiterkrankungen bei Studieneinschluss
boolean
C0009488 (UMLS CUI [1])
Date
Item
Datum
date
C0011008 (UMLS CUI [1])
Patient ID
Item
Patientenidentifikation
integer
C1269815 (UMLS CUI [1])
Comorbidity
Item
Vom Lymphom unabhängige Begleiterkrankung bei Studieneinschluss
text
C0009488 (UMLS CUI [1])
first diagnosis
Item
Erstdiagnose (Jahr)
partialDate
C0205265 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
Comment
Item
Kommentare
text
C0947611 (UMLS CUI [1])
date
Item
Datum der Bearbeitung
date
C0011008 (UMLS CUI [1])
name
Item
Name
text
C0027365 (UMLS CUI [1])
signature
Item
Unterschrift
text
C1519316 (UMLS CUI [1])